Tags

Type your tag names separated by a space and hit enter

Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
Int J Radiat Oncol Biol Phys. 2009 Mar 15; 73(4):1252-9.IJ

Abstract

PURPOSE

To investigate dose-volume effects of salivary flow and the functional recovery over time, using salivary function data and different models of normal tissue complication probability (NTCP).

METHODS AND MATERIALS

A total of 59 patients with head-and-neck cancer treated with intensity-modulated radiotherapy (IMRT) were analyzed in the present study. The toxicity was evaluated using the Radiation Therapy Oncology Group (RTOG) scale and salivary flows, both unstimulated (USF) and stimulated (SSF). The assessments were done before radiotherapy (RT) and at 3, 6, 12, 18, and 24 months after RT. Grade 3 toxicity was the primary endpoint. Analyses of toxicity incidence at 3, 6, and 12 months after RT were performed by both the Lyman-Kutcher-Burman (LKB) and relative seriality (S) models.

RESULTS

A significant correlation was found between the incidence of Grade 3 toxicity and the incidence of patients with a reduction in SSF to <25% of the pre-RT value. Better correlations resulted between the RTOG toxicity score and the dosimetric parameters, compared with USF/SSF. The TD(50), assessed by the LKB model, was 21.4, 27.8, and 41.6 Gy at 3, 6, and 12 months after RT, respectively. The TD(50), assessed by the S model, was 20.0, 26.3, and 40.0 Gy at 3, 6, and 12 months after RT, respectively.

CONCLUSION

Recovery of salivary gland function vs. time after RT took place mostly within 1 year after RT. The RTOG Grade 3 was a reliable score to perform the NTCP modeling. The choice of NTCP model had no influence on the accuracy of predictions.

Authors+Show Affiliations

Laboratorio di Fisica Medica e Sistemi Esperti, Istituto Regina Elena, Rome, Italy. marzi@ifo.itNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19251097

Citation

Marzi, Simona, et al. "Analysis of Salivary Flow and Dose-volume Modeling of Complication Incidence in Patients With Head-and-neck Cancer Receiving Intensity-modulated Radiotherapy." International Journal of Radiation Oncology, Biology, Physics, vol. 73, no. 4, 2009, pp. 1252-9.
Marzi S, Iaccarino G, Pasciuti K, et al. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73(4):1252-9.
Marzi, S., Iaccarino, G., Pasciuti, K., Soriani, A., Benassi, M., Arcangeli, G., Giovinazzo, G., Benassi, M., & Marucci, L. (2009). Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 73(4), 1252-9. https://doi.org/10.1016/j.ijrobp.2008.11.020
Marzi S, et al. Analysis of Salivary Flow and Dose-volume Modeling of Complication Incidence in Patients With Head-and-neck Cancer Receiving Intensity-modulated Radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1252-9. PubMed PMID: 19251097.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy. AU - Marzi,Simona, AU - Iaccarino,Giuseppe, AU - Pasciuti,Katia, AU - Soriani,Antonella, AU - Benassi,Marcello, AU - Arcangeli,Giorgio, AU - Giovinazzo,Giuseppe, AU - Benassi,Michaela, AU - Marucci,Laura, PY - 2008/08/05/received PY - 2008/11/04/revised PY - 2008/11/08/accepted PY - 2009/3/3/entrez PY - 2009/3/3/pubmed PY - 2009/3/26/medline SP - 1252 EP - 9 JF - International journal of radiation oncology, biology, physics JO - Int J Radiat Oncol Biol Phys VL - 73 IS - 4 N2 - PURPOSE: To investigate dose-volume effects of salivary flow and the functional recovery over time, using salivary function data and different models of normal tissue complication probability (NTCP). METHODS AND MATERIALS: A total of 59 patients with head-and-neck cancer treated with intensity-modulated radiotherapy (IMRT) were analyzed in the present study. The toxicity was evaluated using the Radiation Therapy Oncology Group (RTOG) scale and salivary flows, both unstimulated (USF) and stimulated (SSF). The assessments were done before radiotherapy (RT) and at 3, 6, 12, 18, and 24 months after RT. Grade 3 toxicity was the primary endpoint. Analyses of toxicity incidence at 3, 6, and 12 months after RT were performed by both the Lyman-Kutcher-Burman (LKB) and relative seriality (S) models. RESULTS: A significant correlation was found between the incidence of Grade 3 toxicity and the incidence of patients with a reduction in SSF to <25% of the pre-RT value. Better correlations resulted between the RTOG toxicity score and the dosimetric parameters, compared with USF/SSF. The TD(50), assessed by the LKB model, was 21.4, 27.8, and 41.6 Gy at 3, 6, and 12 months after RT, respectively. The TD(50), assessed by the S model, was 20.0, 26.3, and 40.0 Gy at 3, 6, and 12 months after RT, respectively. CONCLUSION: Recovery of salivary gland function vs. time after RT took place mostly within 1 year after RT. The RTOG Grade 3 was a reliable score to perform the NTCP modeling. The choice of NTCP model had no influence on the accuracy of predictions. SN - 1879-355X UR - https://www.unboundmedicine.com/medline/citation/19251097/Analysis_of_salivary_flow_and_dose_volume_modeling_of_complication_incidence_in_patients_with_head_and_neck_cancer_receiving_intensity_modulated_radiotherapy_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0360-3016(08)03799-1 DB - PRIME DP - Unbound Medicine ER -